Resources
About Us
Home Report
Store
South East Asia In Vitro Fertilization (IVF) Market
South East Asia In Vitro Fertilization (IVF) Market Size, Share, Forecast, & Trends Analysis by Type (Natural, Intracytoplasmic, Minimal), Product (Imaging, Cryosystems, IVF Cabinets, Incubator, Media, Sperm Analyzer), Cycle, Application, End User - Forecast to 2031
Report ID:MRHC - 1041441 Pages: 200 Dec-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 HoursThe South East Asia In Vitro Fertilization (IVF) Market was valued at $128.6 million in 2023. This market is expected to reach $222.6 million by 2031 from an estimated $137.7 million in 2024, at a CAGR of 7.1% during the forecast period 2024-2031.
South East Asia In Vitro Fertilization (IVF) Market Size & Forecast
The growth of the South East Asia In Vitro Fertilization (IVF) market is primarily driven by increasing infertility rates, technological advancements in IVF procedures, high success rates of pregnancy through IVF, changing socio-cultural norms, favorable government regulations & policies, and the reducing costs of IVF. Furthermore, the increasing access to preimplantation genetic testing for selecting the best embryos is expected to generate market growth opportunities in the coming years.
Key Findings
- By Type: The Natural IVF Segment to Dominate the South East Asia In Vitro Fertilization (IVF) Market in 2024
- By Product: The Instruments Segment to Dominate the South East Asia In Vitro Fertilization (IVF) Market in 2024
- By Cycle: The Frozen Non-donor IVF Cycles Segment to Dominate the South East Asia In Vitro Fertilization (IVF) Market in 2024
- By Application: The Human Reproduction Segment to Dominate the South East Asia In Vitro Fertilization (IVF) Market in 2024
- By End User: The Hospitals Segment to Dominate the South East Asia In Vitro Fertilization (IVF) Market in 2024
South East Asia In Vitro Fertilization (IVF) Market Growth Drivers
Technological Advancements in IVF Procedures
In Vitro Fertilization (IVF) is becoming an increasingly effective option for couples struggling with infertility. Technological advances, ongoing research, and innovation in the field of reproductive medicine have propelled the demand for IVF. For instance, ovarian tissue cryopreservation is an option for women undergoing cancer treatment who may have compromised fertility. Ovarian tissue cryopreservation allows women to preserve and freeze their ovarian tissue containing viable eggs before undergoing chemotherapy. These tissues can be re-implanted post-treatment.
In addition, advanced time-lapse incubators maintain steady culture conditions for embryos while allowing for continuous monitoring via imaging. They provide optimal embryo development conditions and detailed data on embryo growth, improving the embryo selection process. As research and technology continue to evolve, the chances of success in IVF are steadily improving, which is further driving the growth of the IVF market in South East Asia.
Increasing Infertility Rates
According to the Centers for Disease Control and Prevention (CDC), infertility rates have increased significantly in recent years. For instance, in 2021, the prevalence of infertility per 100,000 individuals was the highest in the Philippines at 3,510.33, followed by Indonesia. As of 2022, the fertility rate average for South East Asian countries was 1.97 births per woman (the Philippines at 2.72 and Singapore at 1.05). Declining fertility rates in the region are attributed to lifestyle factors such as smoking, alcohol use, weight fluctuations, and high stress. Thus, the increasing cases of infertility are driving the demand for IVF.
South East Asia In Vitro Fertilization (IVF) Market Opportunities
Increasing Access to Preimplantation Genetic Testing (PGT) for Selecting the Best Embryos
Preimplantation Genetic Testing (PGT) is a procedure for identifying genetic abnormalities in embryos created for the IVF process. Abnormal embryo genes are one of the common reasons for the failure of pregnancy through IVF. PGT ensures that embryos with the correct number of chromosomes are used, reducing the chances of failure. Preimplantation genetic testing is also carried out for monogenic disorders, structural chromosomal abnormalities, whole chromosome aneuploidy, and other disorders for increasing live birth rates and decreasing overall pregnancy failure rates. Although preimplantation genetic testing cannot identify all genetic abnormalities, prenatal genetic screening can also be performed. For instance, in September 2024, The HiFi Solves Sub-fertility Consortium collaborated with five leading centers across the Asia-Pacific region, such as Singapore's KK Women’s and Children’s Hospital (KKH). This collaboration aims to enhance the diagnosis and treatment of subfertility and recurrent pregnancy loss by using advanced sequencing technologies. Thus, growing collaborations for PGT are expected to create opportunities for market growth.
South East Asia In Vitro Fertilization (IVF) Market Analysis: Key Findings
By Product: The Instruments Segment to Dominate the South East Asia In Vitro Fertilization (IVF) Market
Based on product, the South East Asia In Vitro Fertilization (IVF) market is segmented into instruments, reagents & media, and accessories. In 2024, the instruments segment is expected to account for the largest share of the South East Asia IVF market. The instruments segment is further categorized into imaging systems, ovum aspiration pumps, micromanipulator systems, gas analyzers, incubators, laser analyzers, cry systems, sperm separation devices, sperm analyzer systems, sterile cabinets, and other instruments.
The large share of this segment is attributed to the increasing demand for innovative instruments such as time-lapse incubators, as these incubators enable the monitoring of IVF procedures and assist in the classification of healthy embryos with the highest probability of implantation to achieve higher fertility rates. The rising demand for advanced instruments such as imaging systems, the increasing number of fertility clinics, and the rising demand for advanced technologies for IVF procedures also support the segment’s large share.
Imaging systems are utilized to determine embryo quality, morphology, and developmental stage. Embryologists can utilize high-resolution imaging to analyze embryos for parameters such as cell fragmentation, quantity, and symmetry, which helps them select the most promising embryos for transfer. In addition, imaging systems are used to evaluate and monitor fertility processes such as fertilization rates, sperm-egg interactions, and pronuclei production. In addition, technological advancements in imaging systems offer greater embryo visibility, allowing for better embryo selection and quality assessment, assisting in the precise measurement of embryo growth stages, and resulting in increased IVF success rates. Additionally, the automation features of imaging systems accelerate the IVF process, reducing embryologists' manual effort and improving overall laboratory efficiency.
Geographic Analysis
Indonesia to Dominate the South East Asia In Vitro Fertilization (IVF) Market in 2024
In 2024, Indonesia is expected to account for the largest share of the South East Asia In Vitro Fertilization (IVF) market. Indonesia’s significant market share is attributed to the decreasing fertility rates, growing awareness regarding fertility testing, large demographics, advancements in reproductive technology, and evolving regulatory standards in the country.
Fertility rates in Indonesia have steadily decreased in the past few years due to health issues and socioeconomic changes. According to Macrotrends LLC (U.S.), in 2024, the fertility rate in Indonesia was 2.204 births per woman (2.220 births per woman in 2023 and 2.240 births per woman in 2022). Thus, decreasing fertility rates are increasing the demand for IVF treatments as more couples seek reproductive technologies to overcome infertility challenges.
However, Singapore is slated to register the highest growth rate during the forecast period. The robust healthcare infrastructure, medical tourism, increasing infertility rates, government initiatives and subsidies for fertility treatments, and flexible policies allowing for advancements in IVF technology support the high growth of the IVF market in Singapore. The country’s low fertility rates are attributed to various factors such as delayed parenthood, changing lifestyles, exposure to pollutants, and lack of fertility awareness, increasing the demand for IVF products in Singapore.
South East Asia In Vitro Fertilization (IVF) Market: Key Companies
The report provides a competitive landscape based on an extensive assessment of the leading market players’ offerings, geographic presence, and the key growth strategies adopted by them in recent years (2021-2024). The key players operating in the South East Asia In Vitro Fertilization (IVF) market are Sansure Biotech Inc. (China), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Hologic, Inc. (U.S.), Illumina, Inc. (U.S.), Danaher Corporation (U.S.), QIAGEN N.V. (Netherlands), Abbott Laboratories (U.S.), and Agilent Technologies Inc. (U.S.), among others.
South East Asia In Vitro Fertilization (IVF) Market Overview: Latest Developments from Key Industry Players
- In September 2024, Alpha IVF Group Bhd (Malaysia) expanded its presence in South East Asia by establishing an IVF center in Manila, Philippines. The main objective of the project was to serve the Philippines' 115 million population, where lowering fertility rates indicate an increasing demand for modern reproductive care.
- In October 2023, Cryoport, Inc. (U.S.) signed a three-year supply chain solutions agreement with Monash IVF Group Limited (Australia) for delivering cryogenic logistic solutions and ISO-certified risk mitigation processes for the transportation of patients’ reproductive material across Australia and South East Asia.
- In June 2023, the IVF provider Generation Prime launched its first clinics in Thailand and Malaysia to offer advanced fertility treatments.
South East Asia In Vitro Fertilization Market Research Summary
|
Particulars |
Details |
|
Number of Pages |
200 |
|
Format |
|
|
Forecast Period |
2024-2031 |
|
Base Year |
2023 |
|
CAGR |
7.1% |
|
Estimated Market Size (Value) |
$222.6 million by 2031 |
|
Segments Covered |
By Product
By Type
By Cycle
By Application
By End User
|
|
Countries Covered |
Indonesia, Singapore, Vietnam, Thailand, the Philippines, Malaysia, and the Rest of South East Asia |
|
Key Companies Profiled |
Sansure Biotech Inc. (China), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Hologic, Inc. (U.S.), Illumina, Inc. (U.S.), Danaher Corporation (U.S.), QIAGEN N.V. (Netherlands), Abbott Laboratories (U.S.), and Agilent Technologies Inc. (U.S.) |
Key questions answered in the south east asia in vitro fertilization market report:
The South East Asia In Vitro Fertilization (IVF) market was valued at $1286 million in 2023.
The South East Asia In Vitro Fertilization (IVF) market is projected to grow from $137 million in 2024 to $226.6 million by 2031.
The South East Asia In Vitro Fertilization (IVF) market analysis indicates significant growth, with the market expected to reach $226.6 million by 2031 at a Compound Annual Growth Rate (CAGR) of 7.1% from 2024 to 2031.
The key players operating in the South East Asia in vitro fertilization market are Sansure Biotech Inc. (China), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Hologic, Inc. (U.S.), Illumina, Inc. (U.S.), Danaher Corporation (U.S.), QIAGEN N.V. (Netherlands), Abbott Laboratories (U.S.), and Agilent Technologies Inc. (U.S.), among others.
Elective egg freezing, elective single-embryo transfers, and the integration of AI in IVF treatment are key trends in this market.
By product, the instruments segment is forecasted to hold the largest market share.
By type, the natural IVF segment is forecasted to hold the largest market share.
By cycle, the frozen non-donor IVF cycles segment is forecasted to hold the largest market share.
By application, the human reproduction segment is forecasted to hold the largest market share.
By end user, the hospitals segment is forecasted to hold the largest market share.
The primary drivers for the South East Asia in vitro fertilization market include increasing infertility rates, technological advancements in IVF procedures, high success rates of pregnancy through IVF, changing socio-cultural norms, favorable government regulations & policies, and reducing costs of IVF.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Data Collection & Validation Process
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing & Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Increasing Infertility Rates
4.2.2. Technological Advancements in IVF Procedures
4.2.3. High Success Rates of Pregnancy Through IVF
4.2.4. Changing Socio-cultural Norms
4.2.5. Favorable Government Regulations & Policies
4.2.6. Reducing Costs of IVF
4.3. Restraints
4.3.1. Health Risks & Complications Associated with IVF Treatments
4.3.2. Risk of Unsuccessful Cycles
4.4. Opportunities
4.4.1. Increasing Access to Preimplantation Genetic Testing (PGT) for Selecting the Best Embryos
4.5. Challenges
4.5.1. Limited Availability of Specialized IVF Clinics in Rural Areas
4.5.2. Risk of Birth Defects Among Babies Born Through IVF
4.6. Trends
4.6.1. Elective Egg Freezing
4.6.2. Elective Single-embryo Transfers
4.6.3. Integration of AI into IVF Treatments
4.7. Factor Analysis
4.8. Regulatory Analysis
4.9. Pricing Analysis
4.10. Porter’s Five Forces Analysis
5. South East Asia In Vitro Fertilization Market Assessment—by Product
5.1. Overview
5.2. Instruments
5.2.1. Imaging Systems
5.2.2. Ovum Aspiration Pumps
5.2.3. Micromanipulator Systems
5.2.4. Gas Analyzers
5.2.5. Incubators
5.2.6. Laser Analyzers
5.2.7. Cryosystems
5.2.8. Sperm Separation Devices
5.2.9. Sperm Analyzer Systems
5.2.10. Sterile Cabinets
5.2.11. Other Instruments
5.3. Reagents & Media
5.3.1. IVM Medium & IVF Media
5.3.2. Sperm & Ovum Processing Media
5.3.3. Verification Media
5.3.4. Cryopreservation Media
5.3.5. Staining Kits & QC Beads
5.4. Accessories
5.4.1. Catheters & Cannulas
5.4.2. Needles
5.4.3. Micromanipulation Pipettes
5.4.4. Other Accessories
6. South East Asia In Vitro Fertilization Market Assessment—by Type
6.1. Overview
6.2. Natural IVF
6.3. Minimal Stimulation IVF
6.4. In Vitro Maturation
6.5. Intracytoplasmic Sperm Injection
6.6. Other Types
7. South East Asia In Vitro Fertilization Market Assessment—by Cycle
7.1. Overview
7.2. Frozen Non-donor IVF Cycles
7.3. Fresh Non-donor IVF Cycles
7.4. Fresh Donor IVF Cycles
7.5. Frozen Donor IVF Cycles
8. South East Asia In Vitro Fertilization Market Assessment—by Application
8.1. Overview
8.2. Human Reproduction
8.3. Research & Reproductive Toxicology
9. South East Asia In Vitro Fertilization Market Assessment—by End User
9.1. Overview
9.2. Hospitals
9.3. Fertility Clinics
9.4. Research Institutes
9.5. Cryobanks
10. South East Asia In Vitro Fertilization Market Assessment—by Geography
10.1. Overview
10.2. Indonesia
10.3. Singapore
10.4. Vietnam
10.5. Thailand
10.6. Philippines
10.7. Malaysia
10.8. Rest of South East Asia
11. Competition Analysis
11.1. Overview
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Competitive Dashboard
11.4.1. Industry Leaders
11.4.2. Market Differentiators
11.4.3. Vanguards
11.4.4. Emerging Companies
11.5. Market Share Analysis/Market Rankings of Key Players (2023)
12. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)
12.1. Sansure Biotech Inc.
12.2. F. Hoffmann-La Roche Ltd
12.3. Thermo Fisher Scientific Inc.
12.4. Hologic Inc.
12.5. Danaher Corporation
12.6. Illumina Inc.
12.7. QIAGEN N.V.
12.8. Abbott Laboratories.
12.9. Agilent Technologies Inc.
12.10. Other Companies
(Note: SWOT analysis will be provided for the top 5 companies.)
13. Appendix
13.1. Available Customization
13.2. Related Reports
List of Tables
Table 1 South East Asia In Vitro Fertilization Market, by Product, 2022–2031 (USD Million)
Table 2 South East Asia IVF Instruments Market, by Type, 2022–2031 (USD Million)
Table 3 South East Asia IVF Instruments Market, by Country/Region, 2022–2031 (USD Million)
Table 4 South East Asia IVF Imaging Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 5 South East Asia IVF Ovum Aspiration Pumps Market, by Country/Region, 2022–2031 (USD Million)
Table 6 South East Asia IVF Micromanipulator Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 7 South East Asia IVF Gas Analyzers Market, by Country/Region, 2022–2031 (USD Million)
Table 8 South East Asia IVF Incubators Market, by Country/Region, 2022–2031 (USD Million)
Table 9 South East Asia IVF Laser Analyzers Market, by Country/Region, 2022–2031 (USD Million)
Table 10 South East Asia IVF Cryosystems Market, by Country/Region, 2022–2031 (USD Million)
Table 11 South East Asia IVF Sperm Separation Devices Market, by Country/Region, 2022–2031 (USD Million)
Table 12 South East Asia IVF Sperm Analyzer Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 13 South East Asia IVF Sterile Cabinets Market, by Country/Region, 2022–2031 (USD Million)
Table 14 South East Asia Other IVF Instruments Market, by Country/Region, 2022–2031 (USD Million)
Table 15 South East Asia IVF Reagents & Media Market, by Type, 2022–2031 (USD Million)
Table 16 South East Asia IVF Reagents & Media Market, by Country/Region, 2022–2031 (USD Million)
Table 17 South East Asia IVM Medium & IVF Media Market, by Country/Region, 2022–2031 (USD Million)
Table 18 South East Asia IVF Sperm & Ovum Processing Media Market, by Country/Region, 2022–2031 (USD Million)
Table 19 South East Asia IVF Verification Media Market, by Country/Region, 2022–2031 (USD Million)
Table 20 South East Asia IVF Cryopreservation Media Market, by Country/Region, 2022–2031 (USD Million)
Table 21 South East Asia IVF Staining Kits & QC Beads Market, by Country/Region, 2022–2031 (USD Million)
Table 22 South East Asia IVF Accessories Market, by Type, 2022–2031 (USD Million)
Table 23 South East Asia IVF Accessories Market, by Country/Region, 2022–2031 (USD Million)
Table 24 South East Asia IVF Catheters & Cannulas Market, by Country/Region, 2022–2031 (USD Million)
Table 25 South East Asia IVF Needles Market, by Country/Region, 2022–2031 (USD Million)
Table 26 South East Asia IVF Micromanipulation Pipettes Market, by Country/Region, 2022–2031 (USD Million)
Table 27 South East Asia Other IVF Accessories Market, by Country/Region, 2022–2031 (USD Million)
Table 28 South East Asia Other IVF Accessories Market, by Country/Region, 2022–2031 (USD Million)
Table 29 South East Asia In Vitro Fertilization Market, by Type, 2022–2031 (USD Million)
Table 30 South East Asia Natural IVF Market, by Country/Region, 2022–2031 (USD Million)
Table 31 South East Asia Minimal Stimulation IVF Market, by Country/Region, 2022–2031 (USD Million)
Table 32 South East Asia In Vitro Maturation Market, by Country/Region, 2022–2031 (USD Million)
Table 33 South East Asia Intracytoplasmic Sperm Injection Market, by Country/Region, 2022–2031 (USD Million)
Table 34 South East Asia Other IVF Types Market, by Country/Region, 2022–2031 (USD Million)
Table 35 South East Asia In Vitro Fertilization Market, by Cycle, 2022–2031 (USD Million)
Table 36 South East Asia Frozen Non-donor IVF Cycles Market, by Country/Region, 2022–2031 (USD Million)
Table 37 South East Asia Fresh Non-donor IVF Cycles Market, by Country/Region, 2022–2031 (USD Million)
Table 38 South East Asia Fresh Donor IVF Cycles Market, by Country/Region, 2022–2031 (USD Million)
Table 39 South East Asia Frozen Donor IVF Cycles Market, by Country/Region, 2022–2031 (USD Million)
Table 40 South East Asia In Vitro Fertilization Market, by Application, 2022–2031 (USD Million)
Table 41 South East Asia In Vitro Fertilization Market for Human Reproduction, by Country/Region, 2022–2031 (USD Million)
Table 42 South East Asia In Vitro Fertilization Market for Research & Reproductive Toxicology, by Country/Region, 2022–2031 (USD Million)
Table 43 South East Asia In Vitro Fertilization Market by End User, 2022–2031 (USD Million)
Table 44 South East Asia In Vitro Fertilization Market for Hospitals, by Country/Region, 2022–2031 (USD Million)
Table 45 South East Asia In Vitro Fertilization Market for Fertility Clinics, by Country/Region, 2022–2031 (USD Million)
Table 46 South East Asia In Vitro Fertilization Market for Research Institutes, by Country/Region, 2022–2031 (USD Million)
Table 47 South East Asia In Vitro Fertilization Market for Cryobanks, by Country/Region, 2022–2031 (USD Million)
Table 48 South East Asia In Vitro Fertilization Market, by Country/Region, 2022–2031 (USD Million)
Table 49 South East Asia: In Vitro Fertilization Market, by Cycle, 2022–2031 (USD Million)
Table 50 South East Asia: In Vitro Fertilization Market, by Type, 2022–2031 (USD Million)
Table 51 South East Asia: In Vitro Fertilization Market, by Product, 2022–2031 (USD Million)
Table 52 South East Asia: In Vitro Fertilization Instruments Market, by Type, 2022–2031 (USD Million)
Table 53 South East Asia: In Vitro Fertilization Reagents & Media Market, by Type, 2022–2031 (USD Million)
Table 54 South East Asia: In Vitro Fertilization Accessories Market, by Type, 2022–2031 (USD Million)
Table 55 South East Asia: In Vitro Fertilization Market, by Application, 2022–2031 (USD Million)
Table 56 South East Asia: In Vitro Fertilization Market, by End User, 2022–2031 (USD Million)
Table 57 Indonesia: In Vitro Fertilization Market, by Cycle, 2022–2031 (USD Million)
Table 58 Indonesia: In Vitro Fertilization Market, by Type, 2022–2031 (USD Million)
Table 59 Indonesia: In Vitro Fertilization Market, by Product, 2022–2031 (USD Million)
Table 60 Indonesia: In Vitro Fertilization Instruments Market, by Type, 2022–2031 (USD Million)
Table 61 Indonesia: In Vitro Fertilization Reagents & Media Market, by Type, 2022–2031 (USD Million)
Table 62 Indonesia: In Vitro Fertilization Accessories Market, by Type, 2022–2031 (USD Million)
Table 63 Indonesia: In Vitro Fertilization Market, by Application, 2022–2031 (USD Million)
Table 64 Indonesia: In Vitro Fertilization Market, by End User, 2022–2031 (USD Million)
Table 65 Singapore: In Vitro Fertilization Market, by Cycle, 2022–2031 (USD Million)
Table 66 Singapore: In Vitro Fertilization Market, by Type, 2022–2031 (USD Million)
Table 67 Singapore: In Vitro Fertilization Market, by Product, 2022–2031 (USD Million)
Table 68 Singapore: In Vitro Fertilization Instruments Market, by Type, 2022–2031 (USD Million)
Table 69 Singapore: In Vitro Fertilization Reagents & Media Market, by Type, 2022–2031 (USD Million)
Table 70 Singapore: In Vitro Fertilization Accessories Market, by Type, 2022–2031 (USD Million)
Table 71 Singapore: In Vitro Fertilization Market, by Application, 2022–2031 (USD Million)
Table 72 Singapore: In Vitro Fertilization Market, by End User, 2022–2031 (USD Million)
Table 73 Vietnam: In Vitro Fertilization Market, by Cycle, 2022–2031 (USD Million)
Table 74 Vietnam: In Vitro Fertilization Market, by Type, 2022–2031 (USD Million)
Table 75 Vietnam: In Vitro Fertilization Market, by Product, 2022–2031 (USD Million)
Table 76 Vietnam: In Vitro Fertilization Instruments Market, by Type, 2022–2031 (USD Million)
Table 77 Vietnam: In Vitro Fertilization Reagents & Media Market, by Type, 2022–2031 (USD Million)
Table 78 Vietnam: In Vitro Fertilization Accessories Market, by Type, 2022–2031 (USD Million)
Table 79 Vietnam: In Vitro Fertilization Market, by Application, 2022–2031 (USD Million)
Table 80 Vietnam: In Vitro Fertilization Market, by End User, 2022–2031 (USD Million)
Table 81 Thailand: In Vitro Fertilization Market, by Cycle, 2022–2031 (USD Million)
Table 82 Thailand: In Vitro Fertilization Market, by Type, 2022–2031 (USD Million)
Table 83 Thailand: In Vitro Fertilization Market, by Product, 2022–2031 (USD Million)
Table 84 Thailand: In Vitro Fertilization Instruments Market, by Type, 2022–2031 (USD Million)
Table 85 Thailand: In Vitro Fertilization Reagents & Media Market, by Type, 2022–2031 (USD Million)
Table 86 Thailand: In Vitro Fertilization Accessories Market, by Type, 2022–2031 (USD Million)
Table 87 Thailand: In Vitro Fertilization Market, by Application, 2022–2031 (USD Million)
Table 88 Thailand: In Vitro Fertilization Market, by End User, 2022–2031 (USD Million)
Table 89 Philippines: In Vitro Fertilization Market, by Cycle, 2022–2031 (USD Million)
Table 90 Philippines: In Vitro Fertilization Market, by Type, 2022–2031 (USD Million)
Table 91 Philippines: In Vitro Fertilization Market, by Product, 2022–2031 (USD Million)
Table 92 Philippines: In Vitro Fertilization Instruments Market, by Type, 2022–2031 (USD Million)
Table 93 Philippines: In Vitro Fertilization Reagents & Media Market, by Type, 2022–2031 (USD Million)
Table 94 Philippines: In Vitro Fertilization Accessories Market, by Type, 2022–2031 (USD Million)
Table 95 Philippines: In Vitro Fertilization Market, by Application, 2022–2031 (USD Million)
Table 96 Philippines: In Vitro Fertilization Market, by End User, 2022–2031 (USD Million)
Table 97 Malaysia: In Vitro Fertilization Market, by Cycle, 2022–2031 (USD Million)
Table 98 Malaysia: In Vitro Fertilization Market, by Type, 2022–2031 (USD Million)
Table 99 Malaysia: In Vitro Fertilization Market, by Product, 2022–2031 (USD Million)
Table 100 Malaysia: In Vitro Fertilization Instruments Market, by Type, 2022–2031 (USD Million)
Table 101 Malaysia: In Vitro Fertilization Reagents & Media Market, by Type, 2022–2031 (USD Million)
Table 102 Malaysia: In Vitro Fertilization Accessories Market, by Type, 2022–2031 (USD Million)
Table 103 Malaysia: In Vitro Fertilization Market, by Application, 2022–2031 (USD Million)
Table 104 Malaysia: In Vitro Fertilization Market, by End User, 2022–2031 (USD Million)
Table 105 Rest of South East Asia: In Vitro Fertilization Market, by Cycle, 2022–2031 (USD Million)
Table 106 Rest of South East Asia: In Vitro Fertilization Market, by Type, 2022–2031 (USD Million)
Table 107 Rest of South East Asia: In Vitro Fertilization Market, by Product, 2022–2031 (USD Million)
Table 108 Rest of South East Asia: In Vitro Fertilization Instruments Market, by Type, 2022–2031 (USD Million)
Table 109 Rest of South East Asia: In Vitro Fertilization Reagents & Media Market, by Type, 2022–2031 (USD Million)
Table 110 Rest of South East Asia: In Vitro Fertilization Accessories Market, by Type, 2022–2031 (USD Million)
Table 111 Rest of South East Asia: In Vitro Fertilization Market, by Application, 2022–2031 (USD Million)
Table 112 Rest of South East Asia: In Vitro Fertilization Market, by End User, 2022–2031 (USD Million)
Table 113 Recent Developments, by Company, 2021-2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 South East Asia In Vitro Fertilization Market, by Product, 2024 Vs. 2031 (USD Million)
Figure 8 South East Asia In Vitro Fertilization Market, by Type, 2024 Vs. 2031 (USD Million)
Figure 9 South East Asia In Vitro Fertilization Market, by Cycle, 2024 Vs. 2031 (USD Million)
Figure 10 South East Asia In Vitro Fertilization Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 11 South East Asia In Vitro Fertilization Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 12 South East Asia In Vitro Fertilization Market, by Country/Region 2024 Vs. 2031 (USD Million)
Figure 13 South East Asia In Vitro Fertilization Market, by Product, 2024 Vs. 2031 (USD Million)
Figure 14 South East Asia In Vitro Fertilization Market, by Type, 2024 Vs. 2031 (USD Million)
Figure 15 South East Asia In Vitro Fertilization Market, by Cycle, 2024 Vs. 2031 (USD Million)
Figure 16 South East Asia In Vitro Fertilization Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 17 South East Asia In Vitro Fertilization Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 18 South East Asia: In Vitro Fertilization Market Snapshot
Figure 19 Key Growth Strategies Adopted by Leading Players, 2020–2024
Figure 20 South East Asia In Vitro Fertilization Market: Competitive Benchmarking, by Product
Figure 21 South East Asia In Vitro Fertilization Market: Competitive Benchmarking, by Type
Figure 22 South East Asia In Vitro Fertilization Market: Competitive Dashboard
Figure 23 South East Asia In Vitro Fertilization Market: Market Share Analysis/Market Rankings of Key Players (2023)
Figure 24 F. Hoffmann-La Roche Ltd: Financial Snapshot (2023)
Figure 25 Thermo Fisher Scientific Inc: Financial Snapshot (2023)
Figure 26 Hologic Inc.: Financial Snapshot (2023)
Figure 27 Illumina Inc.: Financial Snapshot (2023)
Figure 28 Danaher Corporation: Financial Snapshot (2023)
Figure 29 QIAGEN N.V.: Financial Snapshot (2023)
Figure 30 Abbott Laboratories: Financial Snapshot (2023)
Figure 31 Agilent Technologies Inc.: Financial Snapshot (2023)
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
In-vitro Diagnostics (IVD) Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Sep-2024
South East Asia Telehealth Market - Opportunity Analysis and Industry Forecast (2024-2030)
Published Date: Jul-2024
South East Asia IVD Market - Opportunity Analysis And Industry Forecast (2024-2030)
Published Date: Jul-2024
South East Asia Orthodontics Market - Opportunity Analysis and Industry Forecast (2024-2030)
Published Date: Jul-2024
In Vitro Fertilization Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Jun-2024
